These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 25497439)

  • 21. Voxel-based mapping of cortical ischemic damage using Tc 99m L,L-ethyl cysteinate dimer SPECT in acute stroke.
    Mahagne MH; David O; Darcourt J; Migneco O; Dunac A; Chatel M; Baron JC
    J Neuroimaging; 2004 Jan; 14(1):23-32. PubMed ID: 14748205
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Minocycline benefits negative symptoms in early schizophrenia: a randomised double-blind placebo-controlled clinical trial in patients on standard treatment.
    Chaudhry IB; Hallak J; Husain N; Minhas F; Stirling J; Richardson P; Dursun S; Dunn G; Deakin B
    J Psychopharmacol; 2012 Sep; 26(9):1185-93. PubMed ID: 22526685
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regional cerebral blood flow and negative/positive symptoms in 24 drug-naive schizophrenics.
    Sabri O; Erkwoh R; Schreckenberger M; Cremerius U; Schulz G; Dickmann C; Kaiser HJ; Steinmeyer EM; Sass H; Buell U
    J Nucl Med; 1997 Feb; 38(2):181-8. PubMed ID: 9025731
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Absence of regional brain volume change in schizophrenia associated with short-term atypical antipsychotic treatment.
    McClure RK; Carew K; Greeter S; Maushauer E; Steen G; Weinberger DR
    Schizophr Res; 2008 Jan; 98(1-3):29-39. PubMed ID: 17976957
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Brain perfusion SPECT in limbic encephalitis associated with autoantibody against the glutamate receptor epsilon 2.
    Kimura N; Kumamoto T; Takahashi Y
    Clin Neurol Neurosurg; 2014 Mar; 118():44-8. PubMed ID: 24529228
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regional change in brain morphometry in schizophrenia associated with antipsychotic treatment.
    McClure RK; Phillips I; Jazayerli R; Barnett A; Coppola R; Weinberger DR
    Psychiatry Res; 2006 Dec; 148(2-3):121-32. PubMed ID: 17097276
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationship between regional cerebral blood flow and separate symptom clusters of major depression: a single photon emission computed tomography study using statistical parametric mapping.
    Périco CA; Skaf CR; Yamada A; Duran F; Buchpiguel CA; Castro CC; Soares JC; Busatto GF
    Neurosci Lett; 2005 Aug; 384(3):265-70. PubMed ID: 15921853
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Depressive mood in pre-dialytic chronic kidney disease: Statistical parametric mapping analysis of Tc-99m ECD brain SPECT.
    Song SH; Kwak IS; Kim SJ; Kim YK; Kim IJ
    Psychiatry Res; 2009 Sep; 173(3):243-7. PubMed ID: 19682866
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SPECT image analysis using statistical parametric mapping: comparison of technetium-99m-HMPAO and technetium-99m-ECD.
    Patterson JC; Early TS; Martin A; Walker MZ; Russell JM; Villanueva-Meyer H
    J Nucl Med; 1997 Nov; 38(11):1721-5. PubMed ID: 9374340
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Omega-3 fatty acid supplementation may prevent loss of gray matter thickness in the left parieto-occipital cortex in first episode schizophrenia: A secondary outcome analysis of the OFFER randomized controlled study.
    Pawełczyk T; Piątkowska-Janko E; Bogorodzki P; Gębski P; Grancow-Grabka M; Trafalska E; Żurner N; Pawełczyk A
    Schizophr Res; 2018 May; 195():168-175. PubMed ID: 29079060
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Whole-brain morphometric study of schizophrenia revealing a spatially complex set of focal abnormalities.
    Davatzikos C; Shen D; Gur RC; Wu X; Liu D; Fan Y; Hughett P; Turetsky BI; Gur RE
    Arch Gen Psychiatry; 2005 Nov; 62(11):1218-27. PubMed ID: 16275809
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of antipsychotic drugs on cortical thickness. A randomized controlled one-year follow-up study of haloperidol, risperidone and olanzapine.
    Roiz-Santiáñez R; Tordesillas-Gutiérrez D; Ortíz-García de la Foz V; Ayesa-Arriola R; Gutiérrez A; Tabarés-Seisdedos R; Vázquez-Barquero JL; Crespo-Facorro B
    Schizophr Res; 2012 Oct; 141(1):22-8. PubMed ID: 22884754
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Extensive gray matter volume reduction in treatment-resistant schizophrenia.
    Anderson VM; Goldstein ME; Kydd RR; Russell BR
    Int J Neuropsychopharmacol; 2015 Feb; 18(7):pyv016. PubMed ID: 25716781
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Add-on treatment of benzoate for schizophrenia: a randomized, double-blind, placebo-controlled trial of D-amino acid oxidase inhibitor.
    Lane HY; Lin CH; Green MF; Hellemann G; Huang CC; Chen PW; Tun R; Chang YC; Tsai GE
    JAMA Psychiatry; 2013 Dec; 70(12):1267-75. PubMed ID: 24089054
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Technetium-99m-ECD brain SPECT in cerebral palsy: comparison with MRI.
    Lee JD; Kim DI; Ryu YH; Whang GJ; Park CI; Kim DG
    J Nucl Med; 1998 Apr; 39(4):619-23. PubMed ID: 9544666
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Brain perfusion SPECT in the mouse: normal pattern according to gender and age.
    Apostolova I; Wunder A; Dirnagl U; Michel R; Stemmer N; Lukas M; Derlin T; Gregor-Mamoudou B; Goldschmidt J; Brenner W; Buchert R
    Neuroimage; 2012 Dec; 63(4):1807-17. PubMed ID: 22971548
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Beneficial antipsychotic effects of allopurinol as add-on therapy for schizophrenia: a double blind, randomized and placebo controlled trial.
    Akhondzadeh S; Safarcherati A; Amini H
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Feb; 29(2):253-9. PubMed ID: 15694232
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Functional involvement of superior temporal sulcus in quality of life of patients with schizophrenia.
    Boyer L; Richieri R; Faget C; Padovani R; Vaillant F; Mundler O; Lançon C; Auquier P; Guedj E
    Psychiatry Res; 2012 May; 202(2):155-60. PubMed ID: 22698762
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antipsychotic drug effects on brain morphology in first-episode psychosis.
    Lieberman JA; Tollefson GD; Charles C; Zipursky R; Sharma T; Kahn RS; Keefe RS; Green AI; Gur RE; McEvoy J; Perkins D; Hamer RM; Gu H; Tohen M;
    Arch Gen Psychiatry; 2005 Apr; 62(4):361-70. PubMed ID: 15809403
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glutamate-N-methyl-D-aspartate receptor modulation and minocycline for the treatment of patients with schizophrenia: an update.
    Chaves C; Marque CR; Trzesniak C; Machado de Sousa JP; Zuardi AW; Crippa JA; Dursun SM; Hallak JE
    Braz J Med Biol Res; 2009 Nov; 42(11):1002-14. PubMed ID: 19855900
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.